ICD-10-CM code · FY2027
F15 Other stimulant related disorders
Header codeNot billable: use one of the 48 billable codes below
About F15
EvidencePulse™by 2 Minute Medicine®
Go deeper into stimulant use.
Ask about the latest evidence, the landmark trials or what guidelines recommend, with every study cited. No ads, no sponsored answers.
Coding notes for F15
Includes Conditions this code covers.
- amphetamine-related disorders
- caffeine
Excludes2 Not part of this condition, but a patient can have both: report both codes when both apply.
- cocaine-related disorders (F14.-)
Chapter 5 notes (apply to every code in it)
Includes Conditions this code covers.
- disorders of psychological development
Codes under F15 60
- F15.1 Other stimulant abuseHeader
- F15.10 Other stimulant abuse, uncomplicatedBillable
- F15.11 Other stimulant abuse, in remissionBillable
- F15.12 Other stimulant abuse with intoxicationHeader
- F15.120 Other stimulant abuse with intoxication, uncomplicatedBillable
- F15.121 Other stimulant abuse with intoxication deliriumBillable
- F15.122 Other stimulant abuse with intoxication with perceptual disturbanceBillable
- F15.129 Other stimulant abuse with intoxication, unspecifiedBillable
- F15.13 Other stimulant abuse with withdrawalBillable
- F15.14 Other stimulant abuse with stimulant-induced mood disorderBillable
- F15.15 Other stimulant abuse with stimulant-induced psychotic disorderHeader
- F15.150 Other stimulant abuse with stimulant-induced psychotic disorder with delusionsBillable
- F15.151 Other stimulant abuse with stimulant-induced psychotic disorder with hallucinationsBillable
- F15.159 Other stimulant abuse with stimulant-induced psychotic disorder, unspecifiedBillable
- F15.18 Other stimulant abuse with other stimulant-induced disorderHeader
- F15.180 Other stimulant abuse with stimulant-induced anxiety disorderBillable
- F15.181 Other stimulant abuse with stimulant-induced sexual dysfunctionBillable
- F15.182 Other stimulant abuse with stimulant-induced sleep disorderBillable
- F15.188 Other stimulant abuse with other stimulant-induced disorderBillable
- F15.19 Other stimulant abuse with unspecified stimulant-induced disorderBillable
- F15.2 Other stimulant dependenceHeader
- F15.20 Other stimulant dependence, uncomplicatedBillable
- F15.21 Other stimulant dependence, in remissionBillable
- F15.22 Other stimulant dependence with intoxicationHeader
- F15.220 Other stimulant dependence with intoxication, uncomplicatedBillable
- F15.221 Other stimulant dependence with intoxication deliriumBillable
- F15.222 Other stimulant dependence with intoxication with perceptual disturbanceBillable
- F15.229 Other stimulant dependence with intoxication, unspecifiedBillable
- F15.23 Other stimulant dependence with withdrawalBillable
- F15.24 Other stimulant dependence with stimulant-induced mood disorderBillable
- F15.25 Other stimulant dependence with stimulant-induced psychotic disorderHeader
- F15.250 Other stimulant dependence with stimulant-induced psychotic disorder with delusionsBillable
- F15.251 Other stimulant dependence with stimulant-induced psychotic disorder with hallucinationsBillable
- F15.259 Other stimulant dependence with stimulant-induced psychotic disorder, unspecifiedBillable
- F15.28 Other stimulant dependence with other stimulant-induced disorderHeader
- F15.280 Other stimulant dependence with stimulant-induced anxiety disorderBillable
- F15.281 Other stimulant dependence with stimulant-induced sexual dysfunctionBillable
- F15.282 Other stimulant dependence with stimulant-induced sleep disorderBillable
- F15.288 Other stimulant dependence with other stimulant-induced disorderBillable
- F15.29 Other stimulant dependence with unspecified stimulant-induced disorderBillable
- F15.9 Other stimulant use, unspecifiedHeader
- F15.90 Other stimulant use, unspecified, uncomplicatedBillable
- F15.91 Other stimulant use, unspecified, in remissionBillable
- F15.92 Other stimulant use, unspecified with intoxicationHeader
- F15.920 Other stimulant use, unspecified with intoxication, uncomplicatedBillable
- F15.921 Other stimulant use, unspecified with intoxication deliriumBillable
- F15.922 Other stimulant use, unspecified with intoxication with perceptual disturbanceBillable
- F15.929 Other stimulant use, unspecified with intoxication, unspecifiedBillable
- F15.93 Other stimulant use, unspecified with withdrawalBillable
- F15.94 Other stimulant use, unspecified with stimulant-induced mood disorderBillable
- F15.95 Other stimulant use, unspecified with stimulant-induced psychotic disorderHeader
- F15.950 Other stimulant use, unspecified with stimulant-induced psychotic disorder with delusionsBillable
- F15.951 Other stimulant use, unspecified with stimulant-induced psychotic disorder with hallucinationsBillable
- F15.959 Other stimulant use, unspecified with stimulant-induced psychotic disorder, unspecifiedBillable
- F15.98 Other stimulant use, unspecified with other stimulant-induced disorderHeader
- F15.980 Other stimulant use, unspecified with stimulant-induced anxiety disorderBillable
- F15.981 Other stimulant use, unspecified with stimulant-induced sexual dysfunctionBillable
- F15.982 Other stimulant use, unspecified with stimulant-induced sleep disorderBillable
- F15.988 Other stimulant use, unspecified with other stimulant-induced disorderBillable
- F15.99 Other stimulant use, unspecified with unspecified stimulant-induced disorderBillable
Other categories in F10-F19
- F10 Alcohol related disordersHeader
- F11 Opioid related disordersHeader
- F12 Cannabis related disordersHeader
- F13 Sedative, hypnotic, or anxiolytic related disordersHeader
- F14 Cocaine related disordersHeader
- F16 Hallucinogen related disordersHeader
- F17 Nicotine dependenceHeader
- F18 Inhalant related disordersHeader
- F19 Other psychoactive substance related disordersHeader
Latest research on stimulant use
- Co-use of methamphetamine and opioids associated with higher rates of nonfatal overdoses compared to independent use
- Exercise and dance may reduce cravings associated with methamphetamine abuse in women
- Naltrexone-bupropion treatment provides a higher response for methamphetamine use disorder
- Looksmaxxing raises body dysmorphia concerns among adolescent males
- The Scan by 2 Minute Medicine®: Viral menopause cocktail lacks evidence, maxxing trends raise dysmorphia concerns, Ebola cases surpass 5,000, and coffee consumption is linked to lower visceral fat
2MM+
Read the research behind every diagnosis
2MM+ gives you every study summary in full, Classics downloads of the landmark trials, EvidencePulse and HypeCheck, and ad-free reading.
See 2MM+ plansICD-10-CM FY2027 code set, as published by the CDC National Center for Health Statistics (NCHS) and CMS, effective October 1, 2026 to September 30, 2027. Codes, titles and notes are shown as published. Check payer rules and the official guidelines before billing. This page is not medical advice.
Get the app